EN
FR
Disease areas
Products
Sustainable business
Careers
About us
Patient help
Insulin 100
Accessibility
Investigator Sponsored Studies
News & media
Contact us
Awiqli
®
– world’s first once-weekly basal insulin–now available in Canada
2024.06.17
Wegovy
®
(semaglutide injection) available in Canada
2024.05.02
Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases
2023.08.10
Aspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesity
2023.04.12
Creation of a National Training Program for Healthcare Professionals Involved in Obesity Prevention and Care
2022.04.05
Continued Support for Banting and Best’s Insulin Discovery and Research at the University of Toronto
2021.04.12
Novo Nordisk and the University of Toronto announce joint 200 DKK million investment to address diabetes and chronic disease prevention
2021.02.24
Camp Huronda receives $1.5M donation to rebuild on-site medical centre
2021.01.14
Camp Huronda infographic
2021.01.14